<DOC>
	<DOCNO>NCT01490203</DOCNO>
	<brief_summary>The purpose study determine whether global segmental hepatic uptake excretion Gd-EOB-DTPA Gd-EOB-DTPA-enhanced liver MRI correlate standard liver function test result patient Hepatocellular Carcinoma ( HCC ) major hepatic resection radiofrequency ablation ( RFA ) .</brief_summary>
	<brief_title>Evaluation Remnant Liver Function Using Primovist-enhanced MRI Before Resection/Ablation Hepatocellular Carcinoma</brief_title>
	<detailed_description>1 . Preoperative/RFA assessment remnant liver function important avoid posthepatectomy liver failure . However , function future remnant decrease patient chronic liver disease cirrhosis , compare healthy patient equal volume . Therefore , volume-based estimation hepatic reserve function inadequate patient hepatic dysfunction . 2 . Standard clinical liver function test , ICG clearance rate Child-Pugh score , provide measurement global hepatic function , evaluate functional distribution liver . Gd-EOB-DTPA ( Gadoxetic acid , PrimovistÂ® , Bayer Schering ) enhance MRI recently demonstrate potential imaging-based liver function test , possibility detect functional difference regional even segmental level . 3 . Gd-EOB-DTPA-enhanced liver MRI may able ass global also segmental liver function patient hepatocellular carcinoma ( HCC ) relatively high risk develop liver failure surgical resection due coexistent hepatic damage chronic viral hepatitis and/or cirrhosis preoperatively . The purpose study determine whether global segmental hepatic uptake excretion Gd-EOB-DTPA Gd-EOB-DTPA-enhanced liver MRI correlate standard liver function test result patient HCC major hepatic resection/RFA .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<mesh_term>Pentetic Acid</mesh_term>
	<mesh_term>Edetic Acid</mesh_term>
	<criteria>1 . Patients diagnosis HCC base noninvasive diagnostic criterion HCC propose 2010 AASLD 2 . Surgical resection hepatic resection great 2 Couinaud segment ( include total hepatectomy transplantation ) radiofrequency ablation plan 3 . Patients provide informed consent 1 . Patients young 18 yr old 2 . Patients receive hepatic surgery prior study 3 . Patients underwent TACE RFA great 2 segment within 3 month prior study 4 . Patients receive radiation treatment include liver systemic chemotherapy 5 . Patients underwent contrast enhance liver MRI within 3 day prior study 6 . Patients severe renal dysfunction ( Cr .2.5 mg/dL GFR &lt; 30mL/min ) 7 . Patients hypersensitivity gadolinium 8 . Patients uncorrectable hypokalemia 9 . Pregnant woman , reproductive age woman agree contraception study period . 10 . Patients mental disorder interfere voluntary agreement 11 . Patients contraindication MRI ( cardiac pacemaker , ferromagnetic implant , etc . ) 12 . Any condition , opinion Investigator , would make patient unsuitable enrollment could interfere completion study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Gd-EOB-DTPA</keyword>
	<keyword>MRI</keyword>
	<keyword>Hepatectomy</keyword>
	<keyword>Hepatocellular Carcinoma</keyword>
	<keyword>Liver Function Tests</keyword>
</DOC>